Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker
Conditions: Atrial Fibrillation; Left Atrial Rhythm Interventions: Drug: Digoxin 0.25 mg; Drug: Bisoprolol Sponsor: University of Monastir Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials
EvaLuation of early CRRT and beta-blocker InTervention in patients with ECMO (ELITE) trial: study protocol for a 2 × 2 partial factorial randomized controlled trial
DiscussionThis trial will help define the role of early CRRT and beta-blockade in ECMO patients. There have been 89 patients enrolled at 10 hospitals in study A and is ongoing. However, study B was stopped in August 2019 in the absence of any patients being enrolled.Trial registrationClinicalTrials.govNCT03549923. Registered on 8 June 2018. World Health Organization International Clinical Trials Registry Platform (WHO ICTEP) network. The Ethics Committee of Beijing Anzhen Hospital Approval ID is 2018013. (Source: Trials)
Source: Trials - August 19, 2022 Category: Research Source Type: clinical trials
WithDRawal Impact Of Postoperative Beta-Blocker
Condition: Coronary Artery Bypass Intervention: Other: Discontinuing all beta-blocker Sponsors: Yale University; Glenn Memorial Fund Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2022 Category: Research Source Type: clinical trials
